Compounded GLP-1 drops or tablets vs injections: do the oral versions work?

Yes, FDA-approved oral GLP-1 versions (specifically semaglutide and orforglipron) work effectively, producing clinically meaningful weight loss and blood sugar improvements, though they are generally slightly less potent than their injectable counterparts.

Key Differences in Efficacy

• Weight Loss: Oral GLP-1s typically result in 10–14% body weight loss, whereas injections often achieve 15–20%.
  • Oral semaglutide (Wegovy): Average loss of 13.6% over 71 weeks[5].
  • Injectable semaglutide: Average loss of ~15% over a similar period[5].
  • Orforglipron (Foundayo): Average loss of 12% over 72 weeks, with some trials showing up to 14% at the highest dose[3][5].
• Blood Sugar (A1c): Injections typically reduce A1c by 1.5–2.0% points, while oral versions reduce it by 1.0–1.5% points[1]. Orforglipron has shown superior A1c reduction (2.2%) compared to oral semaglutide (1.4%) in head-to-head trials[3].

Important Warning: Compounded vs. FDA-Approved

It is critical to distinguish between FDA-approved pills and compounded drops/tablets:

• FDA-Approved (Effective): Products like Wegovy (oral semaglutide) and Foundayo (orforglipron) have been tested in large clinical trials and are proven to work[3][5].
• Compounded/Drops (Likely Ineffective): There is no published human study demonstrating that sublingual semaglutide drops or compounded tablets produce meaningful weight loss[4].
  • Experts warn that compounded formulations can break down during digestion, leading to variable dosing and variable or zero efficacy[3][9].
  • User reports indicate that online "GLP-1 Oral Solutions" often fail completely, with users experiencing no appetite reduction[6].

Recommendation

If you are considering an oral GLP-1, only pursue FDA-approved oral tablets (semaglutide or orforglipron) prescribed by a licensed healthcare provider. Avoid "compounded" options or sublingual drops, as they lack clinical evidence of efficacy and may expose you to safety risks[3][4].

• Best for Diabetes: Orforglipron (Foundayo) due to superior A1c reduction[3].
• Best for Weight Loss (Pill): High-dose oral semaglutide (Wegovy) or orforglipron, both approaching 14–17% loss in some trials[3][7].
• Best Overall (if you can inject): Injectable GLP-1s remain the most consistent option for maximum weight loss (15–20%)[5][7].